ArriVent BioPharma (AVBP) Total Current Liabilities (2023 - 2026)
ArriVent BioPharma (AVBP) reported Total Current Liabilities of $27.84 million for Q2 2026, up 41.8% from $19.64 million a year earlier and up 11.4% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Total Current Liabilities (2023 - 2026) Analysis & Trends
At the end of FY2025, ArriVent BioPharma posted Total Current Liabilities of $25.95 million, up 50.2% from FY2024.
- By year, Total Current Liabilities came in at $17.27 million in FY2024 (+48.6%) and $11.62 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Total Current Liabilities in data going back to Q4 2023.
- Year over year, Total Current Liabilities has now increased in each of the last seven quarters, with growth averaging 52.6% over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $25 million (Q1 2026), $25.95 million (Q4 2025) and $21.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 27.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.84 Mn |
| Mar 31, 2026 | 25.00 Mn |
| Dec 31, 2025 | 25.95 Mn |
| Sep 30, 2025 | 21.56 Mn |
| Jun 30, 2025 | 19.64 Mn |
| Mar 31, 2025 | 12.95 Mn |
| Dec 31, 2024 | 17.27 Mn |
| Sep 30, 2024 | 15.16 Mn |
| Jun 30, 2024 | 12.10 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 11.62 Mn |
API Access
ArriVent BioPharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();